High Risk of Colorectal Cancer After High‐Grade Dysplasia in Inflammatory Bowel Disease Patients
The risk of synchronous and metachronous CRC after a diagnosis of high-grade dysplasia underlines the high-risk profile of this subgroup of patients with inflammatory bowel disease. The possible advantages of colon-sparing treatment should be balanced with the higher risk of metachronous CRC and the subsequent need for stringent endoscopic surveillance.
Authors
- Frank Hoentjen (ORCID: https://orcid.org/0000-0001-5314-4452)
- Monica E. W. Derks (ORCID: https://orcid.org/0000-0002-4247-3987)
- Maarten te Groen (ORCID: https://orcid.org/0000-0002-9323-1486)
- L Derikx (ORCID: https://orcid.org/0000-0002-4081-8451)
- Iris D. Nagtegaal
Institutions
- Radboud University Nijmegen (NL)
- University of Alberta (CA)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- Koninklijke Nederlandse Maatschappij voor Diergeneeskunde (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1111/apt.70429
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63